We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 21 JUNE 2013
Client Alert
Brinks Gilson & Lione
In a unanimous decision in Association for Molecular Pathology, et. al. v. Myriad Genetics, Inc. et. al., the U.S. Supreme Court found "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated."
United StatesIntellectual Property








